Xiaoyuan Xu, Huiguo Ding, Hong You, Yujuan Guan, Jinghang Xu, Wengang Li, Ying Han, Yaping Wang, Yifan Han, Jidong Jia, Lai Wei, Zhongping Duan, Y. Nan, Zhuang Hui, Chinese Society of Hepatology, Chinese Medical Association
Abstract
The Chinese Society of Hepatology of the Chinese Medical Association has invited experts in relevant fields to revise and rename the 2019 “Chinese Guidelines on the Management of Liver Cirrhosis” to “Chinese Guidelines for Clinical Diagnosis, Treatment, and Management of Cirrhosis (2025)”. These updated guidelines are aimed at providing recommendations for the clinical diagnosis and management of liver cirrhosis across the compensated, decompensated, and recompensated stages, as well as guidance on cirrhosis reversal and associated complications.
Citation format
XU, Xiaoyuan, et al. Chinese guidelines for clinical diagnosis, treatment, and management of cirrhosis (2025). Journal of Clinical and Translational Hepatology, 2026, 14(000): 96–115.